Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris
Public ClinicalTrials.gov record NCT02965456. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2-Arm, Parallel Group Comparison Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study was to evaluate the efficacy, safety, and tolerability of a once daily topical application of IDP-121 Lotion compared with its vehicle (IDP-121 Vehicle Lotion) in participants with moderate to severe acne vulgaris (acne) (that is, acne having an Evaluator's Global Severity Score \[EGSS\] of 3 \[moderate\] or 4 \[severe\]).
Study identification
- NCT ID
- NCT02965456
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 820 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 9 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 3, 2015
- Primary completion
- Feb 22, 2017
- Completion
- Feb 22, 2017
- Last update posted
- Dec 17, 2019
2015 – 2017
United States locations
- U.S. sites
- 34
- U.S. states
- 16
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Valeant Site 21 | Glendale | Arizona | 85308 | — |
| Valeant Site 34 | Rogers | Arkansas | 72758 | — |
| Valeant Site 25 | Anaheim | California | 92801 | — |
| Valeant Site 18 | Beverly Hills | California | 90210 | — |
| Valeant Site 09 | Fremont | California | 94538 | — |
| Valeant Site 17 | Murrieta | California | 92526 | — |
| Valeant Site 26 | Oxnard | California | 93035 | — |
| Valeant Site 22 | Sacramento | California | 95819 | — |
| Valeant Site 02 | San Diego | California | 92123 | — |
| Valeant Site 04 | San Diego | California | 92123 | — |
| Valeant Site 19 | Santa Monica | California | 90404 | — |
| Valeant Site 15 | Miami | Florida | 33015 | — |
| Valeant Site 11 | Miami | Florida | 33144 | — |
| Valeant Site 27 | Pinellas Park | Florida | 33782 | — |
| Valeant Site 31 | Sanford | Florida | 32771 | — |
| Valeant Site 05 | Tampa | Florida | 33624 | — |
| Valeant Site 28 | Marietta | Georgia | 30060 | — |
| Valeant Site 16 | Buffalo Grove | Illinois | 60089 | — |
| Valeant Site 06 | Indianapolis | Indiana | 46256 | — |
| Valeant Site 12 | Overland Park | Kansas | 66215 | — |
| Valeant Site 32 | Crowley | Louisiana | 70526 | — |
| Valeant Site 30 | Clarkston | Michigan | 48346 | — |
| Valeant Site 03 | Detroit | Michigan | 48302 | — |
| Valeant Site 20 | Henderson | Nevada | 89074 | — |
| Valeant Site 08 | New York | New York | 10016 | — |
| Valeant Site 23 | Winston-Salem | North Carolina | 27104 | — |
| Valeant Site 29 | Hazleton | Pennsylvania | 18201 | — |
| Valeant Site 24 | Johnston | Rhode Island | 02919 | — |
| Valeant Site 10 | Austin | Texas | 78759 | — |
| Valeant Site 01 | Houston | Texas | 77065 | — |
| Valeant Site 33 | Port Arthur | Texas | 77460 | — |
| Valeant Site 07 | San Antonio | Texas | 78229 | — |
| Valeant Site 13 | San Antonio | Texas | 78229 | — |
| Valeant Site 14 | San Antonio | Texas | 78249 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Acne trials
Other public records listing Acne. Sorted by last update posted; newest first. Not a recommendation.
- NCT07013747: Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild Acne Recruiting
- NCT06989840: Phase 1 Study to Evaluate the Safety, Tolerability, PK, and PD of TVB-3567 in Healthy Participants With or Without Acne Recruiting
- NCT06316297: Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne Recruiting
- NCT04582383: Comparative Effectiveness Study of Spironolactone Versus Doxycycline for Acne Active, not recruiting
- NCT05582434: Experience With Topical Acne Treatment Active, not recruiting
- NCT06202274: Clinical Study to Evaluate the Safety and Efficacy of Candela Technology Active, not recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02965456, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 17, 2019 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02965456 live on ClinicalTrials.gov.